<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zaric M</submitter><funding>The Slovenian Research and Innovation Agency</funding><pagination>11910</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12732864</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(24)</volume><pubmed_abstract>Cathepsin B (CatB) is a lysosomal cysteine protease that plays a major role in various pathologies and is therefore considered a valuable therapeutic target. To address species-specific inhibitor challenges, we characterized the selective binding of designed ankyrin repeat protein (DARPin) 4m3 toward mouse cathepsin B (mCatB) over human CatB (hCatB). The mCatB-DARPin 4m3 complex was validated by size-exclusion chromatography (SEC), nano-differential scanning fluorimetry (nano-DSF), and surface plasmon resonance (SPR), revealing high affinity binding (K&lt;sub>D&lt;/sub> = 65.7 nM) and potent inhibition (Ki = 26.7 nM; mixed competitive/noncompetitive). DARPin 4m3 showed no binding/inhibition toward hCatB. The 1.67 Å crystal structure of the complex-the first for mCatB-identified key interaction r</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Structural and Proteomic Analysis of the Mouse Cathepsin B-DARPin 4m3 Complex Reveals Species-Specific Binding Determinants.</pubmed_title><pmcid>PMC12732864</pmcid><funding_grant_id>P1-0140; P1-0048</funding_grant_id><pubmed_authors>Novak M</pubmed_authors><pubmed_authors>Turk B</pubmed_authors><pubmed_authors>Gevaert K</pubmed_authors><pubmed_authors>Usenik A</pubmed_authors><pubmed_authors>Turk D</pubmed_authors><pubmed_authors>Kramer L</pubmed_authors><pubmed_authors>Vasiljeva O</pubmed_authors><pubmed_authors>Impens F</pubmed_authors><pubmed_authors>Tusar L</pubmed_authors><pubmed_authors>Zaric M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural and Proteomic Analysis of the Mouse Cathepsin B-DARPin 4m3 Complex Reveals Species-Specific Binding Determinants.</name><description>Cathepsin B (CatB) is a lysosomal cysteine protease that plays a major role in various pathologies and is therefore considered a valuable therapeutic target. To address species-specific inhibitor challenges, we characterized the selective binding of designed ankyrin repeat protein (DARPin) 4m3 toward mouse cathepsin B (mCatB) over human CatB (hCatB). The mCatB-DARPin 4m3 complex was validated by size-exclusion chromatography (SEC), nano-differential scanning fluorimetry (nano-DSF), and surface plasmon resonance (SPR), revealing high affinity binding (K&lt;sub>D&lt;/sub> = 65.7 nM) and potent inhibition (Ki = 26.7 nM; mixed competitive/noncompetitive). DARPin 4m3 showed no binding/inhibition toward hCatB. The 1.67 Å crystal structure of the complex-the first for mCatB-identified key interaction r</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-05-28T03:21:15.918Z</modification><creation>2026-05-28T03:11:44.65Z</creation></dates><accession>S-EPMC12732864</accession><cross_references><pubmed>41465336</pubmed><doi>10.3390/ijms262411910</doi></cross_references></HashMap>